Comparison between Cyient Ltd. Buyback 2026 and Windlas Biotech Buyback 2026.
Cyient Ltd. Buyback 2026 is a Tender Offer buyback proposed to list at BSE, NSE while Windlas Biotech Buyback 2026 is a Tender Offer proposed to list at BSE, NSE.
| Cyient Ltd. | Windlas Biotech Ltd | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Logo |  |  | |||||||||
| Type of Buyback | Tender Offer | Tender Offer | |||||||||
| Listing At | BSE, NSE | BSE, NSE | |||||||||
| Face Value | ₹5 per share | ₹5 per share | |||||||||
| Buyback Price | ₹1125 per share | ₹1000 per share | |||||||||
| Issue Size | 64,00,000 shares | 4,70,000 shares | |||||||||
| Issue Size (Amount) | ₹720.00 Crores | ₹47.00 Crores | |||||||||
| Buyback Ratio |
Note:
| ||||||||||
| Registrar | MUFG Intime India Pvt.Ltd. | ||||||||||
| Lead Managers | Fintellectual Corporate Advisors Pvt.Ltd. | ||||||||||
| Necessity of the buyback | The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
|
Cyient Ltd. Buyback 2026 and Windlas Biotech Buyback 2026 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Cyient Ltd. Buyback 2026 Buyback record date is . Windlas Biotech Buyback 2026 Buyback record date is Apr 24, 2026.
| Cyient Ltd. | Windlas Biotech Ltd | |
|---|---|---|
| Record Date | Apr 24, 2026 | |
| Offer Open Date | Apr 30, 2026 | |
| Offer Closure Date | May 07, 2026 | |
| Last date for receipt of tender forms | May 07, 2026 | |
| Finalisation of buyback | May 13, 2026 | |
| Last Date for settlment of bids | Apr 14, 2026 | |
| Last Date for extinguishment of shares | May 25, 2026 |
Comparison of Cyient Ltd. Buyback 2026 and Windlas Biotech Buyback 2026 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
| Cyient Ltd. | Windlas Biotech Ltd | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Company Financials (Restated Consolidated)Cyient Ltd.'s revenue decreased by 1% and profit after tax (PAT) dropped by 12% between the financial year ending with March 31, 2026 and March 31, 2025.
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||
| Stock price at BSE | Stock price at BSE (in preceding 3 months)
| ||||||||||||||||||||||||||||||||||
| Stock price at NSE | Stock price at NSE (in preceding 3 months)
| ||||||||||||||||||||||||||||||||||
